<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2017-4-155-164</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-1033</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Ранние маркеры фенотипической гетерогенности системной красной волчанки в экспериментальной модели</article-title><trans-title-group xml:lang="en"><trans-title>Early markers of phenotypic heterogeneity in the induced model of systemic lupus erythematosus</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Kолесникова</surname><given-names>О. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikova</surname><given-names>O. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, зав. лабораторией</p><p>лаборатория ýкспериментальной иммунотерапии</p><p>630099, г. Новосибирск, ул. Ядринцевская, 14 </p></bio><bio xml:lang="en"><p>DM, Head of the Laboratory of Experimental Immunotherapy</p><p>14, Str. Yadrintsevskaya, 630099, Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гойман</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Goiman</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, науч. сотрудник</p><p>лаборатория ýкспериментальной иммунотерапии</p><p>630099, г. Новосибирск, ул. Ядринцевская, 14 </p></bio><bio xml:lang="en"><p>PhD, Researcher, Laboratory of Experimental Immunotherapy</p><p>14, Str. Yadrintsevskaya, 630099, Novosibirsk</p></bio><email xlink:type="simple">l.goiman@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демченко</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Gavrilova</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. биол. наук, науч. сотрудник</p><p>лаборатория ýкспериментальной иммунотерапии</p><p>630099, г. Новосибирск, ул. Ядринцевская, 14 </p></bio><bio xml:lang="en"><p>PhD, Researcher, Laboratory of Experimental Immunotherapy</p><p>14, Str. Yadrintsevskaya, 630099, Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гаврилова</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Demchenko</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. хим. наук, науч. сотрудник</p><p>лаборатория ýкспериментальной иммунотерапии</p><p>630099, г. Новосибирск, ул. Ядринцевская, 14 </p></bio><bio xml:lang="en"><p>PhD, Researcher, Laboratory of Experimental Immunotherapy</p><p>14, Str. Yadrintsevskaya, 630099, Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>академик РАН, научный руководитель </p><p>630099, г. Новосибирск, ул. Ядринцевская, 14 </p></bio><bio xml:lang="en"><p>Academician of the Russian Academy of Sciences, Scientific Supervisor </p><p>14, Str. Yadrintsevskaya, 630099, Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт фундаментальной и клинической иммунологии (НИИФиКИ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Fundamental and Clinical Immunology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>02</day><month>01</month><year>2018</year></pub-date><volume>16</volume><issue>4</issue><fpage>155</fpage><lpage>164</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kолесникова О.П., Гойман Е.В., Демченко Е.Н., Гаврилова Е.Д., Козлов В.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Kолесникова О.П., Гойман Е.В., Демченко Е.Н., Гаврилова Е.Д., Козлов В.А.</copyright-holder><copyright-holder xml:lang="en">Kolesnikova O.P., Goiman E.V., Gavrilova E.D., Demchenko E.N., Kozlov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/1033">https://bulletin.ssmu.ru/jour/article/view/1033</self-uri><abstract><p>Цель работы – выявление на основе индуцируемой воспалительной реакции у интактных мышей предрасположенности к дальнейшему развитию разных клинических вариантов системной красной волчанки.</p><sec><title>Материал и методы</title><p>Материал и методы. Низкодозовый системный воспалительный ответ моделировали введением липополисахарида (ЛПС) интактным самкам мышей-гибридов (C57BL/6xDBA/2)F1 (B6D2F1) внутрибрюшинно в дозе 10 нг/мышь или 1 мкг/мышь. Динамику ответа на ЛПС оценивали через 2, 4, 8, 11, 24 ч, а также на 4- и 8-й нед от момента индукции модели по числу форменных элементов крови (лейкоцитов, нейтрофилов, лимфоцитов), а также соотношению нейтрофилы / лимфоциты (индекс N/L), уровню внеклеточной ДНК (внДНК). Через 1 сут после введения ЛПС у мышей индуцировали модель системной красной волчанки (СКВ): самкам мышей B6D2F1 вводили по 120 × 106 клеток селезенки мышей родительской линии DBA/2. Через 3 мес от момента индукции модели у мышей двукратно измеряли уровень белка в моче: при протеинурии 3 мг/мл и более мышей относили к группе CКВнефрит+, при наличии белка в моче менее 3 мг/мл – к группе CКВнефрит–.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что введение ЛПС не влияет на соотношение групп CКВнефрит+/CКВнефрит–. Ретроспективный анализ количества лейкоцитов, нейтрофилов, лимфоцитов не позволяет прогнозировать развитие нефрита. При введении ЛПС в дозе 10 нг/мышь наблюдалось достоверное увеличение частоты и абсолютного прироста индекса N/L на 8-й нед относительно 4-й нед после индукции модели в группе CКВнефрит+ по сравнению с группой CКВнефрит–. При введении ЛПС в дозе 1мкг/мышь мыши CКВнефрит+ и CКВнефрит– обнаруживают разную динамику воспалительного ответа по приросту индекса N/L в каждой последующей точке относительно предыдущей. Изменение уровня внДНК в группе CКВнефрит+ и CКВнефрит– аналогично динамике индекса N/L. Таким образом, полученные данные свидетельствуют о возможности использования параметров воспалительного процесса, в частности индекса N/L и уровня внДНК, для прогноза предрасположенности животного к развитию разных вариантов СКВ.A / 2 parent mice twice </p></sec></abstract><trans-abstract xml:lang="en"><p>The study aimed at evaluating the predisposition for development of different variants of SLE based on an inflammatory response in intact mice.</p><sec><title>Materials and methods</title><p>Materials and methods. Low-dose systemic inflammatory response was modeled by the administration of lipopolysaccharide (LPS) of E. coli (strain 111: B4) by intact B6D2F1 recipients in the dose of 10 ng/mouse or 1 μg / mouse. We evaluated the number of leukocytes, neutrophils, and lymphocytes in the blood, the index of neutrophils / lymphocytes (ratio N/L), and the level of free DNA (cf DNA cell free) in dynamics. The first day after LPS injection we induced SLE model: the female B6D2F1 mice were injected 60–70 x 106 spleen cells of the DBA / 2 parent mice twice with interval five days. Three months after the induction of the model, the level of protein in the urine was measured twice: the mice with proteinuria 3 mg/ml and more were assigned to the group SLEnephritis+, and mice with less than 3 mg/ml of protein in the urine were assigned to the group SLEnephritis–.</p></sec><sec><title>Results</title><p>Results. It was established that administration of LPS does not change the frequency of nephritis in mice. The retrospective analysis of the number of leukocytes, neutrophils, and lymphocytes does not allow the prediction of the development of nephritis. We observed a significant increase in the frequency and the absolute value of the N/L index at week 8 relative to 4 weeks four weeks before the appearance of proteinuria in the group of mice SLEnephritis+ in contrast to mice SLEnephritis– when LPS was administered at a dose of 10 ng/mouse. Mice SLEnephritis+ and SLEnephritis– show different kinetics of the inflammatory response by an increase in the N/L index every subsequent hour relative to the previous one when LPS was administered at a dose of 1 μg/mouse. The dynamics of the cfDNA level is similar to the kinetics of an index N/L in the group SLEnephritis+ and the SLEnephritis–. The data obtained indicate the possibility of using of the index N/L and cfDNA level as a parameter of inflammatory response in mice and prediction of the susceptibility the development of nephritis. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>липополисахарид</kwd><kwd>индекс N/L</kwd><kwd>внДНК</kwd><kwd>модель системной красной волчанки</kwd><kwd>фенотипическая гетерогенность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>LPS</kwd><kwd>index N/L</kwd><kwd>cfDNA</kwd><kwd>SLE model</kwd><kwd>phenotyping heterogeneity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y., Zeumer L., Reeves W., More L. Induced murine models of systemic lupus erythematosus // Methods Mol. Biol. 2014; 1134: 103–130.</mixed-citation><mixed-citation xml:lang="en">Xu Y., Zeumer L., Reeves W., More L. Induced murine models of systemic lupus erythematosus // Methods Mol. Biol. 2014; 1134: 103–130.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kudaeva O.T., Kolesnikova O.P., Goiman E.V., Tkachev V.O., Volsky N.N., Perminova O.M., Gavrilova E.D., Kozlov V.A. The Experimental Model of the Autoimmune Glomerulonephritis Induced by the Chronic Graft versus Host Reaction. In: Prabhakar S. (Ed.). An Update on Glomerulopathies – Etiology and Pathogenesis. InTech, 2011: 49–86. ISBN 978-953-307-388-0.</mixed-citation><mixed-citation xml:lang="en">Kudaeva O.T., Kolesnikova O.P., Goiman E.V., Tkachev V.O., Volsky N.N., Perminova O.M., Gavrilova E.D., Kozlov V.A. The Experimental Model of the Autoimmune Glomerulonephritis Induced by the Chronic Graft versus Host Reaction. In: Prabhakar S. (Ed.). An Update on Glomerulopathies – Etiology and Pathogenesis. InTech, 2011: 49–86. ISBN 978-953-307-388-0.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Колесникова О.П., Кудаева О.Т., Вольский Н.Н., Гойман Е.В., Гаврилова Е.Д., Перминова О.М., Демченко Е.Н., Козлов В.А. Экспериментальная модель аутоиммунного процесса: роль ýпигенетической изменчивости в популяции мышей-гибридов // Вестник РАМН. 2015; 70 (2): 152–158. Kolesnikova O.P., Kudaeva O.T., Volsky N.N., Goiman E.V., Gavrilova E.D., Perminova O.M., Demchenko E.N., Kozlov V.A. Eksperimental’naya model’ autoimmunnogo protsessa: rol’ epigeneticheskoy izmenchivosti v populyatsii myshey-gibridov. [Experimental model of autoimmune process: the role of epigenetic variability in the population of hybrid mice] // Vestnik RAMN – Bulletin of the Russian Academy of Medical Sciences. 2015; 70 (2): 152–158 (in Russian).</mixed-citation><mixed-citation xml:lang="en">Колесникова О.П., Кудаева О.Т., Вольский Н.Н., Гойман Е.В., Гаврилова Е.Д., Перминова О.М., Демченко Е.Н., Козлов В.А. Экспериментальная модель аутоиммунного процесса: роль ýпигенетической изменчивости в популяции мышей-гибридов // Вестник РАМН. 2015; 70 (2): 152–158. Kolesnikova O.P., Kudaeva O.T., Volsky N.N., Goiman E.V., Gavrilova E.D., Perminova O.M., Demchenko E.N., Kozlov V.A. Eksperimental’naya model’ autoimmunnogo protsessa: rol’ epigeneticheskoy izmenchivosti v populyatsii myshey-gibridov. [Experimental model of autoimmune process: the role of epigenetic variability in the population of hybrid mice] // Vestnik RAMN – Bulletin of the Russian Academy of Medical Sciences. 2015; 70 (2): 152–158 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Salem D., Subang R., Laplante P., Levine J.S., Rauch J. The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus // Lupus. 2014; 23 (12):1327–1331.</mixed-citation><mixed-citation xml:lang="en">Salem D., Subang R., Laplante P., Levine J.S., Rauch J. The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus // Lupus. 2014; 23 (12):1327–1331.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Patel P.N., Shah R.Y., Ferguson J.F., Reilly M.P. Human Experimental Endotoxemia in Modeling the Pathophysiology, Genomics and Therapeutics of Innate Immunity in Complex Cardiometabolic Diseases // Arterioscler Thromb. Vasc. Biol. 2015; 35 (3): 525–534.</mixed-citation><mixed-citation xml:lang="en">Patel P.N., Shah R.Y., Ferguson J.F., Reilly M.P. Human Experimental Endotoxemia in Modeling the Pathophysiology, Genomics and Therapeutics of Innate Immunity in Complex Cardiometabolic Diseases // Arterioscler Thromb. Vasc. Biol. 2015; 35 (3): 525–534.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kimura M., Gleichmann E. Depressed antibody responses to exogenous antigens in mice with lupus-like graft-versus-host disease // Clin. Immunol. Immunopathol. 1987; 43 (1): 97–109.</mixed-citation><mixed-citation xml:lang="en">Kimura M., Gleichmann E. Depressed antibody responses to exogenous antigens in mice with lupus-like graft-versus-host disease // Clin. Immunol. Immunopathol. 1987; 43 (1): 97–109.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Колесникова О.П., Кудаева О.Т., Логинов В.А., Робинсон М.В., Колесникова С.М., Козлов В.А. Показатели ýритро- и иммунопоýза в развитии аутоиммунных заболеваний, индуцированных хронической реакцией трансплантат против хозяина // Вестн. АМН СССР. 1991; 12: 13–16. Kolesnikova O.P., Kudaeva O.T., Loginov V.A., Robinson M.V., Kolesnikova S.M., Kozlov V.A. Pokazateli eritroi immunopoeza v razvitii autoimmunnykh zabolevaniy, indutsirovannykh khronicheskoy reaktsiyey transplantat protiv khozyaina [The parameters of erythro- and immunopoiesis in the development of autoimmune diseases induced by the chronic graft versus host reaction] // Vestnik AMN SSSR. 1991; 12: 13–16 (in Russian).</mixed-citation><mixed-citation xml:lang="en">Колесникова О.П., Кудаева О.Т., Логинов В.А., Робинсон М.В., Колесникова С.М., Козлов В.А. Показатели ýритро- и иммунопоýза в развитии аутоиммунных заболеваний, индуцированных хронической реакцией трансплантат против хозяина // Вестн. АМН СССР. 1991; 12: 13–16. Kolesnikova O.P., Kudaeva O.T., Loginov V.A., Robinson M.V., Kolesnikova S.M., Kozlov V.A. Pokazateli eritroi immunopoeza v razvitii autoimmunnykh zabolevaniy, indutsirovannykh khronicheskoy reaktsiyey transplantat protiv khozyaina [The parameters of erythro- and immunopoiesis in the development of autoimmune diseases induced by the chronic graft versus host reaction] // Vestnik AMN SSSR. 1991; 12: 13–16 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Власов В.В., Рыкова Е.Ю., Сафронова И.В., Лактионов П.В., Кудаева О.Т., Козлов В.А. Модуляция течения хронической реакции трансплантат против хозяина // Доклады академии наук. 2002; 32 (6): 844–846. Vlasov V.V., Rykova E.Yu., Safronova I.V., Laktionov P.V., Kudaeva O.T., Kozlov V.A. Modulyatsiya techeniya khronicheskoy reaktsii transplantat protiv khozyaina [Modulation of the course of the chronic graft-versus-host reaction] // Doklady akademii nauk. 2002; 32 (6): 844–846 (in Russian).</mixed-citation><mixed-citation xml:lang="en">Власов В.В., Рыкова Е.Ю., Сафронова И.В., Лактионов П.В., Кудаева О.Т., Козлов В.А. Модуляция течения хронической реакции трансплантат против хозяина // Доклады академии наук. 2002; 32 (6): 844–846. Vlasov V.V., Rykova E.Yu., Safronova I.V., Laktionov P.V., Kudaeva O.T., Kozlov V.A. Modulyatsiya techeniya khronicheskoy reaktsii transplantat protiv khozyaina [Modulation of the course of the chronic graft-versus-host reaction] // Doklady akademii nauk. 2002; 32 (6): 844–846 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cavallo T., Granholm N. Accelerated (proliferative) lupus nephritis // American Journal of Pathology. 1990; 137 (6): 1549–1551.</mixed-citation><mixed-citation xml:lang="en">Cavallo T., Granholm N. Accelerated (proliferative) lupus nephritis // American Journal of Pathology. 1990; 137 (6): 1549–1551.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Eisenbarth S., Piggott D., Huleatt J., Visintin I., Herrick C., Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen // J. Exp. Med. 2002; 196: 1645–1651.</mixed-citation><mixed-citation xml:lang="en">Eisenbarth S., Piggott D., Huleatt J., Visintin I., Herrick C., Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen // J. Exp. Med. 2002; 196: 1645–1651.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kiers D., Koch R., Hamers L., Gerretsen J., Thijs E., van Ede L., Riksen N., Kox M., Pickkers P. Characterization of a model of systemic inflammation in humans in vivo elicited by continuous infusion of endotoxin // Scientific Reports. 2017; 7: 40149. DOI: 10.1038/srep40149.</mixed-citation><mixed-citation xml:lang="en">Kiers D., Koch R., Hamers L., Gerretsen J., Thijs E., van Ede L., Riksen N., Kox M., Pickkers P. Characterization of a model of systemic inflammation in humans in vivo elicited by continuous infusion of endotoxin // Scientific Reports. 2017; 7: 40149. DOI: 10.1038/srep40149.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pajkrt D., Manten A., van der Poll T., Tiel-van Buul M.M., Jansen J., Wouter ten Cate J., van Deventer S. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans // Blood. 1997; 90: 1415–24.</mixed-citation><mixed-citation xml:lang="en">Pajkrt D., Manten A., van der Poll T., Tiel-van Buul M.M., Jansen J., Wouter ten Cate J., van Deventer S. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans // Blood. 1997; 90: 1415–24.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Marsik C., Mayr F., Cardona F., Schaller G., Wagner O., Jilma B. Endotoxin down-modulates P-selectin glycoprotein ligand-1 (PSGL-1, CD162) on neutrophils in humans // J. Clin. Immunol. 2004; 24: 62–65.</mixed-citation><mixed-citation xml:lang="en">Marsik C., Mayr F., Cardona F., Schaller G., Wagner O., Jilma B. Endotoxin down-modulates P-selectin glycoprotein ligand-1 (PSGL-1, CD162) on neutrophils in humans // J. Clin. Immunol. 2004; 24: 62–65.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Гойман Е.В., Кудаева О.Т., Ильина Н.А., Борисов В.И., Кожевников В.С., Колесникова О.П., Козлов В.А. Процессы гомеостатической пролиферации в патогенезе аутоиммунного гломерулонферита, индуцированного хронической реакцией «трансплантат против хозяина» // Бюллетень экспериментальной биологии и медицины. 2010; 149 (1): 60–63. Goiman E.V., Kudaeva O.T., Ilina N.A., Borisov V.I., Kozhevnikov V.S., Kolesnikova O.P., Kozlov V.A. Protsessy gomeostaticheskoy proliferatsii v patogeneze autoimmunnogo glomerulonferita, indutsirovannogo khronicheskoy reaktsiyey «transplantat protiv khozyaina» [The processes of homeostatic proliferation in the pathogenesis of autoimmune glomerulonferitis, induced by the chronic “graft versus host” reaction] // Byulleten’ ehksperimental’noj biologii i mediciny – Bulletin of Experimental Biology and Medicine. 2010; 149 (1): 60–63 (in Russian).</mixed-citation><mixed-citation xml:lang="en">Гойман Е.В., Кудаева О.Т., Ильина Н.А., Борисов В.И., Кожевников В.С., Колесникова О.П., Козлов В.А. Процессы гомеостатической пролиферации в патогенезе аутоиммунного гломерулонферита, индуцированного хронической реакцией «трансплантат против хозяина» // Бюллетень экспериментальной биологии и медицины. 2010; 149 (1): 60–63. Goiman E.V., Kudaeva O.T., Ilina N.A., Borisov V.I., Kozhevnikov V.S., Kolesnikova O.P., Kozlov V.A. Protsessy gomeostaticheskoy proliferatsii v patogeneze autoimmunnogo glomerulonferita, indutsirovannogo khronicheskoy reaktsiyey «transplantat protiv khozyaina» [The processes of homeostatic proliferation in the pathogenesis of autoimmune glomerulonferitis, induced by the chronic “graft versus host” reaction] // Byulleten’ ehksperimental’noj biologii i mediciny – Bulletin of Experimental Biology and Medicine. 2010; 149 (1): 60–63 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Lu X., Xiong R., Wang S. High Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Mortality in Chronic Hemodialysis Patients // Mediators Inflamm. 2017. DOI: 10.1155/2017/9327136.</mixed-citation><mixed-citation xml:lang="en">Li H., Lu X., Xiong R., Wang S. High Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Mortality in Chronic Hemodialysis Patients // Mediators Inflamm. 2017. DOI: 10.1155/2017/9327136.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Seong M.K. Prognostic inflammation score in surgical patients with colorectal cancer // Korean. Med. Sci. 2015; 30: 1793–1799.</mixed-citation><mixed-citation xml:lang="en">Seong M.K. Prognostic inflammation score in surgical patients with colorectal cancer // Korean. Med. Sci. 2015; 30: 1793–1799.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Huang W., Huang J., Liu Q., Lin F., He Z., Zeng Z., He L. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy // Clin. Endocrinol. 2014; 82: 229–33.</mixed-citation><mixed-citation xml:lang="en">Huang W., Huang J., Liu Q., Lin F., He Z., Zeng Z., He L. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy // Clin. Endocrinol. 2014; 82: 229–33.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y., Yang X., Chen L., Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus // International Immunopharmacology. 2016; 36: 94–99.</mixed-citation><mixed-citation xml:lang="en">Chen Y., Yang X., Chen L., Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus // International Immunopharmacology. 2016; 36: 94–99.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Li L., Xia Y., Chen C., Cheng P., Peng C. Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study // Int. J. Clin. Exp Med. 2015; 8 (7): 11026–11031.</mixed-citation><mixed-citation xml:lang="en">Li L., Xia Y., Chen C., Cheng P., Peng C. Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study // Int. J. Clin. Exp Med. 2015; 8 (7): 11026–11031.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Waldman M., Madaio M.: Pathogenic autoantibodies in lupus nephritis // Lupus. 2005; 14: 19–24.</mixed-citation><mixed-citation xml:lang="en">Waldman M., Madaio M.: Pathogenic autoantibodies in lupus nephritis // Lupus. 2005; 14: 19–24.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lam N.Y.L., Rainer T.H., Chan L.Y.S., Joynt G.J., Lo Y.M.D. Time course of early and late changes in plasma DNA in trauma patients // Clin. Chem. 2003; (49): 1286–1291.</mixed-citation><mixed-citation xml:lang="en">Lam N.Y.L., Rainer T.H., Chan L.Y.S., Joynt G.J., Lo Y.M.D. Time course of early and late changes in plasma DNA in trauma patients // Clin. Chem. 2003; (49): 1286–1291.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Atamaniuk J., Kopecky C., Skoupy S., Säemann M.D., Weichhart T. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients // Nephrol. Dial. Transplant. 2012; 27 (3): 902–905. DOI: 10.1093/ndt/ gfr695.</mixed-citation><mixed-citation xml:lang="en">Atamaniuk J., Kopecky C., Skoupy S., Säemann M.D., Weichhart T. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients // Nephrol. Dial. Transplant. 2012; 27 (3): 902–905. DOI: 10.1093/ndt/ gfr695.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang S., Lu X., Shu X., Tian X.. et al. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus // Intern. Med. 2014; 53: 2763–71.</mixed-citation><mixed-citation xml:lang="en">Zhang S., Lu X., Shu X., Tian X.. et al. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus // Intern. Med. 2014; 53: 2763–71.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Leifer C.A., Medvedev A.E. Molecular mechanisms of regulation of Toll-like receptor signaling // J. Leukoc Biol. 2016; 100 (5): 927–941.</mixed-citation><mixed-citation xml:lang="en">Leifer C.A., Medvedev A.E. Molecular mechanisms of regulation of Toll-like receptor signaling // J. Leukoc Biol. 2016; 100 (5): 927–941.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Bao W., Qin X., Guan N., Wang S., Zhu J., Sun X., Zhou H., Zhu Z., Zhu C. MyD88-silenced dendritic cells induce T-cell hyporesponsiveness and promote Th2 polarization in vivo // Cytotherapy. 2015; 17: 1240–1250.</mixed-citation><mixed-citation xml:lang="en">Bao W., Qin X., Guan N., Wang S., Zhu J., Sun X., Zhou H., Zhu Z., Zhu C. MyD88-silenced dendritic cells induce T-cell hyporesponsiveness and promote Th2 polarization in vivo // Cytotherapy. 2015; 17: 1240–1250.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
